This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients with multiple myeloma
Number of approved sites
M1000 Biobank participants
Please join us for our annual Interest Group breakfast at Blood 2023, 6th November.Read more
The MRDR recruits another hospital for the Myeloma 1000 Project.Read more
MY-PROMPT-2 project randomises first patient and enrols another!Read more